Executive Vice President, Global Operations · HAEMONETICS CORP (HAE)

Neil Ryding

A named executive officer of HAEMONETICS in every fiscal year CompBrief holds from FY2017 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$1,090,617

Salary $432,223Stock awards $329,081

FY2017: $1,417,202

5th of 5 named executive officers at Haemonetics by FY2018 total.

5 named officers on file for HAEMONETICS, FY2018

Neil Ryding’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • HAE’s disclosed peer group of 16 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how HAEMONETICS’s whole pay program stands against its peers

  • HAEMONETICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on HAE→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed June 12, 2018 (DEF 14A).

Free

Get Neil Ryding’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Neil Ryding compensation by year

HAEMONETICS Summary Compensation Table · all 2 fiscal years held
In US dollars, as HAEMONETICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018
Salary$428,248$432,223
Bonus$0$0
Stock awards$337,942$329,081
Option awards$112,498$99,992
Non-equity incentive$198,877$208,634
Pension and deferred compensation—$0
All other$317,431$20,688
Total$1,417,202$1,090,617

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: HAEMONETICS CORP DEF 14A filed June 12, 2018, accession 0000313143-18-000033, and prior-year filings. Open the filing on EDGAR.

How this page was built: the HAEMONETICS CORP filed document, accession 0000313143-18-000033. Every figure is read from that document and cited to the page and table it appears in. Filed June 12, 2018.

$1.4M
$1.1M
FY17
FY18
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
PSU6,577$481,173—
PSU4,803$351,387—
RSU2,466$180,413—
RSU2,401$175,657—
RSU2,111$154,441—
Option10,641—$34.21
Option21,655—$31.97
Option9,836—$41.64

Per the Outstanding Equity Awards at Fiscal Year-End table in HAEMONETICS CORP's FY2018 proxy; value at the fiscal year-end close, as the company printed it.

HAEMONETICS’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Christopher SimonPresident and Chief Executive Officer$7,845,796
Michelle BasilExecutive Vice President, General Counsel$2,082,208
William BurkeExecutive Vice President, Chief Financial Officer$2,004,748
Jacqueline ScanlanSenior Vice President, Global Human Resources$1,419,149
Neil Ryding · this pageExecutive Vice President, Global Operations$1,090,617

The full HAEMONETICS compensation record

free company brief

This page is one person within HAEMONETICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the HAEMONETICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are HAEMONETICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Neil Ryding's compensation dossier · One-time report. No refunds.